» Articles » PMID: 37007025

Inhibits Cancer Cells Growth by Inducing G2/M Arrest

Overview
Journal Front Pharmacol
Date 2023 Apr 3
PMID 37007025
Authors
Affiliations
Soon will be listed here.
Abstract

(CR) is one of the most widely used traditional Chinese medicine (TCM) with anti-cancer effects. Analyzing transcriptomic responses of different human cell lines to TCM treatment is a promising approach to understand the unbiased mechanism of TCM. This study treated ten cancer cell lines with different CR concentrations, followed by mRNA sequencing. Differential expression (DE) analysis and gene set enrichment analysis (GSEA) were utilized to analyze transcriptomic data. Finally, the screening results were verified by experiments. Both DE and GSEA analysis suggested the Cell cycle pathway was the most perturbated pathway by CR across these cell lines. By analyzing the clinical significance and prognosis of G2/M related genes (PLK1, CDK1, CCNB1, and CCNB2) in various cancer tissues, we found that they were up-regulated in most cancer types, and their down-regulation showed better overall survival rates in cancer patients. Finally, experiments validation on A549, Hep G2, and HeLa cells suggested that CR can inhibit cell growth by suppressing the PLK1/CDK1/ Cyclin B axis. This is the first study to apply transcriptomic analysis to investigate the cancer cell growth inhibition of CR on various human cancer cell lines. The core effect of CR on ten cancer cell lines is to induce G2/M arrest by inhibiting the PLK1/CDK1/Cyclin B axis.

Citing Articles

Novel Camptothecin Derivative 9c with Enhanced Antitumor Activity via NSA2-EGFR-P53 Signaling Pathway.

Du F, Zhang A, Qi X, Yin R, Jiang T, Li J Int J Mol Sci. 2025; 26(5).

PMID: 40076615 PMC: 11900506. DOI: 10.3390/ijms26051987.


Impact of Linggui Zhugan decoction on microwave ablation outcomes and recurrence in liver cancer.

Huang R, Cui J World J Gastrointest Oncol. 2025; 17(2):101177.

PMID: 39958537 PMC: 11756010. DOI: 10.4251/wjgo.v17.i2.101177.


Elucidating the anti-cancer potential of essential oil against non-small cell lung cancer: A multifaceted approach involving GC-MS profiling, network pharmacology, and molecular dynamics simulations.

Mohanty D, Padhee S, Priyadarshini A, Champati B, Das P, Jena S Heliyon. 2024; 10(6):e28026.

PMID: 38533033 PMC: 10963383. DOI: 10.1016/j.heliyon.2024.e28026.


Nitidine chloride inhibits G2/M phase by regulating the p53/14-3-3 Sigma/CDK1 axis for hepatocellular carcinoma treatment.

Zhang B, Zhou B, Huang G, Huang J, Lin X, Li Z Heliyon. 2024; 10(1):e24012.

PMID: 38283241 PMC: 10818205. DOI: 10.1016/j.heliyon.2024.e24012.

References
1.
Li Y, Liu X, Du A, Zhu X, Yu B . miR-203 accelerates apoptosis and inflammation induced by LPS via targeting NFIL3 in cardiomyocytes. J Cell Biochem. 2018; 120(4):6605-6613. DOI: 10.1002/jcb.27955. View

2.
Xu H, Zhang Y, Liu Z, Chen T, Lv C, Tang S . ETCM: an encyclopaedia of traditional Chinese medicine. Nucleic Acids Res. 2018; 47(D1):D976-D982. PMC: 6323948. DOI: 10.1093/nar/gky987. View

3.
Wang S, Sun X, An S, Sang F, Zhao Y, Yu Z . High-Throughput Identification of Organic Compounds from Polygoni Multiflori Radix Praeparata () by UHPLC-Q-Exactive Orbitrap-MS. Molecules. 2021; 26(13). PMC: 8428211. DOI: 10.3390/molecules26133977. View

4.
Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

5.
Ge S, Son E, Yao R . iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinformatics. 2018; 19(1):534. PMC: 6299935. DOI: 10.1186/s12859-018-2486-6. View